We are live on
!
Find out more
Pictet Asset Management Portfolio holdings
AUM
$105B
1-Year Est. Return
38.07%
This Fund
S&P 500
This Quarter
Est. Return
-2.95%
1 Year Est. Return
+38.07%
3 Year Est. Return
+113.98%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$94.8B
AUM Growth
-$8.26B
(-8%)
Cap. Flow
-$2.48B
Cap. Flow
% of AUM
-2.61%
Top 10 Holdings %
Top 10 Hldgs %
21.55%
Holding
2,181
New
100
Increased
1,075
Reduced
690
Closed
79
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$671M |
| 2 |
Broadcom
AVGO
|
+$416M |
| 3 |
ServiceNow
NOW
|
+$264M |
| 4 |
Arista Networks
ANET
|
+$262M |
| 5 |
Autodesk
ADSK
|
+$235M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lam Research
LRCX
|
+$284M |
| 2 |
Microsoft
MSFT
|
+$281M |
| 3 |
Micron Technology
MU
|
+$275M |
| 4 |
Teradyne
TER
|
+$274M |
| 5 |
KLA
KLAC
|
+$243M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.64% |
| 2 | Industrials | 14.32% |
| 3 | Healthcare | 12.96% |
| 4 | Financials | 7.97% |
| 5 | Utilities | 7.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
476
Viking Therapeutics
VKTX
$3.98B
| $22.7M | 0.02% |
696,301
-56,431
| -7% | -$1.81M |
|
477
Robinhood
HOOD
$85.2B
| $22.6M | 0.02% |
327,018
-73,807
| -18% | -$6.48M |
|
478
Manulife Financial
MFC
$73B
| $22.5M | 0.02% |
654,036
-24,910
| -4% | -$897K |
|
479
CBRE Group
CBRE
$42.6B
| $22.4M | 0.02% |
165,058
-4,514
| -3% | -$686K |
|
480
PayPal
PYPL
$50.1B
| $22.3M | 0.02% |
493,345
-461,450
| -48% | -$22.3M |
|
481
Supernus Pharmaceuticals
SUPN
$2.71B
| $22.3M | 0.02% |
450,764
-32,635
| -7% | -$1.66M |
|
482
AerCap
AER
$23.6B
| $22.3M | 0.02% |
162,455
-3,712
| -2% | -$531K |
|
483
Copart
CPRT
$26.8B
| $22.1M | 0.02% |
665,623
-2,877,981
| -81% | -$108M |
|
484
CF Industries
CF
$17.8B
| $22.1M | 0.02% |
169,795
-21,975
| -11% | -$2.24M |
|
485
Apogee Therapeutics
APGE
$10.2B
| $22M | 0.02% |
261,050
-51,833
| -17% | -$3.76M |
|
486
Martin Marietta Materials
MLM
$32.7B
| $21.9M | 0.02% |
37,286
+1,577
| +4% | +$1.01M |
|
487
MakeMyTrip
MMYT
$5.68B
| $21.8M | 0.02% |
585,369
-119,084
| -17% | -$6.9M |
|
488
Ingevity
NGVT
$2.63B
| $21.5M | 0.02% |
301,903
-57,307
| -16% | -$3.92M |
|
489
State Street
STT
$52B
| $21.1M | 0.02% |
166,605
-7,516
| -4% | -$961K |
|
490
Old Dominion Freight Line
ODFL
$44B
| $21M | 0.02% |
107,647
-241
| -0.2% | -$44.9K |
|
491
Apollo Global Management
APO
$81.9B
| $20.9M | 0.02% |
187,233
-10,596
| -5% | -$1.31M |
|
|
SLNO
492
DELISTED
Soleno Therapeutics
SLNO
| $20.6M | 0.02% |
616,217
-7,911
| -1% | -$310K |
|
|
HOLX
493
DELISTED
Hologic
HOLX
| $20.5M | 0.02% |
271,426
-60,343
| -18% | -$4.54M |
|
494
MetLife
MET
$61.4B
| $20.4M | 0.02% |
288,779
-42,605
| -13% | -$3.19M |
|
495
Trevi Therapeutics
TRVI
$2.51B
| $20.4M | 0.02% |
1,706,048
+174,035
| +11% | +$1.95M |
|
|
SUNB
496
Sunbelt Rentals Holdings
SUNB
$32.6B
| $20.3M | 0.02% |
+324,463
| New | +$22.8M |
|
|
QXO
497
QXO Inc
QXO
$16.1B
| $20.2M | 0.02% |
1,039,849
-252,839
| -20% | -$5.78M |
|
498
Becton Dickinson
BDX
$49.5B
| $20.1M | 0.02% |
128,156
-27,156
| -17% | -$4.99M |
|
499
Quest Diagnostics
DGX
$26.2B
| $20.1M | 0.02% |
102,338
-59,915
| -37% | -$11.6M |
|
500
Roper Technologies
ROP
$38.8B
| $20M | 0.02% |
56,603
-477,374
| -89% | -$176M |
|
Similar funds
Pictet Asset Management's Q1 2026 Portfolio in Review
As of Q1 2026, Pictet Asset Management held 2,181 positions worth $94.8B, down 8% from $103B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Pictet Asset Management's Q1 2026 filing shows 100 new, 1,075 increased, 690 reduced and 79 closed positions. Its largest new stake was AstraZeneca: 3,481,864 shares worth $675M. The largest sale was Lam Research, an estimated $284M.
By sector, the portfolio is most concentrated in Technology at 35% of assets, down from 35% a quarter earlier, followed by Industrials and Healthcare.
- Pictet Asset Management's largest Q1 2026 buy was AstraZeneca: 3,481,864 shares worth $675M.
- Pictet Asset Management added most to Broadcom in Q1 2026, an estimated $416M increase.
- Pictet Asset Management's biggest Q1 2026 reduction was Lam Research, cutting an estimated $284M.
- Pictet Asset Management fully exited CyberArk in Q1 2026, selling an estimated $104M.
- Pictet Asset Management's ten largest holdings make up 22% of its $94.8B portfolio in Q1 2026.
- Pictet Asset Management opened 100 new positions and closed 79 in Q1 2026.
- Pictet Asset Management's portfolio value fell 8% quarter-over-quarter to $94.8B.
Based on Pictet Asset Management's 13F filing for Q1 2026, filed 22 Apr 2026.